AP
ACCPL
Accretion Pha.
Pharmaceuticals
Share price
₹202
Market cap
₹141 Cr
A pharmaceutical manufacturer incorporated in 2012, Accretion Pharmaceuticals produces tablets, capsules, and other healthcare products for domestic and international markets. The company operates across multiple therapeutic segments, focusing on formulation development, quality manufacturing, and distribution. Its distinctive strength lies in vertically integrated operations combining research capabilities with modern production facilities and a wide distribution network across India and select overseas regions.
Investors holding Accretion Pha.
2.76%
Latest move
Unicorn FundNew position
Unicorn Fund acquired 3,07,200 shares, representing a 2.76% stake in Accretion Pharmaceuticals, for ₹4.77 crore at ₹155.50 per share.
Sign in to read more
Whales made 1 more move in Accretion Pha.
Sign in to see who is buying and selling.
Sign in to find out